☆ 4.6 Article

Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Engineering, Biomedical

Conventional versus restricted Anti-Xa-Guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation

Afrah Alkazemi et al.

Summary: This study compared the effectiveness and safety of conventional and restricted anticoagulation protocols in ECMO patients, finding that the restricted protocol was associated with lower transfusion rates and required fewer heparin infusion adjustments.

ARTIFICIAL ORGANS (2022)

添加到收藏夹

Article Engineering, Biomedical

2021 ELSO Adult and Pediatric Anticoagulation Guidelines

Ali B. McMichael et al.

Summary: These guidelines provide educational information for adult and pediatric anticoagulation in extracorporeal membrane oxygenation, aiming to support physicians and other health professionals in assessing and managing patients undergoing ECLS / ECMO. However, they are not consensus recommendations and do not guarantee successful outcomes. Adherence to guidelines should be coupled with clinical judgment and individual patient consultation.

ASAIO JOURNAL (2022)

添加到收藏夹

Article Engineering, Biomedical

Comparison of Bivalirudin Versus Unfractionated Heparin for Anticoagulation in Adult Patients on Extracorporeal Membrane Oxygenation

Erica A. Sheridan et al.

Summary: Extracorporeal membrane oxygenation (ECMO) patients require systemic anticoagulation to prevent coagulopathy. This study compared the safety and efficacy of bivalirudin and unfractionated heparin (UFH) in ECMO patients. The results showed similar rates of bleeding and thrombosis, but bivalirudin demonstrated better control of therapeutic range.

ASAIO JOURNAL (2022)

添加到收藏夹

Article Critical Care Medicine

Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis

Jose Nunez et al.

Summary: This study aimed to analyze the prevalence, mortality association, and risk factors for bleeding and thrombosis events among adults supported with venovenous extracorporeal membrane oxygenation. Bleeding and thrombotic events are common during VV-ECMO and have a strong, cumulative association with in-hospital mortality. While thrombotic events are more frequent, bleeding carries a higher risk of inpatient mortality. Differential risk factors for bleeding and thrombotic complications exist, suggesting the possibility of a tailored approach to VV-ECMO management.

INTENSIVE CARE MEDICINE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Heparin-induced thrombocytopenia in extra-corporeal membrane oxygenation: epidemiology, outcomes, and diagnostic challenges

Akram M. Zaaqoq et al.

Summary: The study found a low prevalence of HIT in patients requiring ECMO support, but it remains associated with high mortality rates. The current ELISA performance as a screening test is poor, but altering the definition of a positive OD can improve its accuracy.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

添加到收藏夹

Article Engineering, Biomedical

Unfractionated Heparin Versus Subcutaneous Nadroparin in Adults Supported With Venovenous Extracorporeal Membrane Oxygenation: a Retrospective, Multicenter Study

Pawel Piwowarczyk et al.

Summary: This study evaluated the safety and feasibility of using subcutaneous nadroparin compared with unfractionated heparin during respiratory ECMO. The results showed that nadroparin was equivalent to unfractionated heparin in terms of bleeding and thrombotic events, life-threatening bleeding incidence, and daily red blood cell transfusion rates during venovenus-ECMO.

ASAIO JOURNAL (2021)

添加到收藏夹

Review Engineering, Biomedical

Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review

Sven R. Olson et al.

Summary: The study reviewed thrombosis and bleeding outcomes in ECMO patients without continuous systemic anticoagulation. Results showed that while the incidence of bleeding and thrombosis was higher, the risk of circuity and patient thrombosis in anticoagulant-free ECMO patients was comparable to those receiving continuous systemic anticoagulation during ECMO.

ASAIO JOURNAL (2021)

添加到收藏夹

Article Engineering, Biomedical

Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients

Caitlin E. Kulig et al.

Summary: This study compared the safety and efficacy of using aPTT and anti-Xa monitoring for UFH in adult venoarterial ECMO patients, finding that the aPTT group took longer to reach the target UFH rate, had higher UFH rates, and overall higher exposure.

ASAIO JOURNAL (2021)

添加到收藏夹

Article Engineering, Biomedical

Thromboelastometry, Thromboelastography, and Conventional Tests to Assess Anticoagulation During Extracorporeal Support: A Prospective Observational Study

Marco Giani et al.

Summary: Optimal anticoagulation monitoring is crucial in ECMO patients to prevent complications. This study evaluated the use of ROTEM compared to TEG and conventional coagulation tests in assessing hemostasis during ECMO, finding moderate correlation with standard tests for INTEM CT but not for Kaolin R time. Additional studies are needed to establish appropriate anticoagulation targets for ROTEM during ECMO.

ASAIO JOURNAL (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator

Abdulrazaq Al-Jazairi et al.

Summary: The study aimed to assess the correlation of UFH dosing and monitoring using an established protocol. Results showed that the anti-factor Xa assay had the largest number of strong correlations, indicating the need for further studies on the safety and different monitoring modalities.

ANNALS OF PHARMACOTHERAPY (2021)

添加到收藏夹

Article Anesthesiology

Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation

Zhen Guo et al.

Summary: This study found that COVID-19 patients during ECMO support are prone to hypercoagulability and secondary hyperfibrinolysis, which may lead to thrombotic events and oxygenator failure. Proper anticoagulation management and monitoring strategies are crucial in preventing related complications.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis

Ariane Willems et al.

Summary: A comparative study of anticoagulation strategies in patients receiving ECMO treatment revealed that an anti-Xa-based approach was associated with fewer bleeding events and lower mortality rates compared to a time-based strategy, with no significant increase in thrombotic events.

PERFUSION-UK (2021)

添加到收藏夹

Article Health Care Sciences & Services

A new anticoagulation strategy using recombinant human thrombomodulin in patients on veno-venous extracorporeal membrane oxygenation: a retrospective study

Norihisa Yasuda et al.

Summary: The study of 15 patients on VV-ECMO using rhTM as an anticoagulant showed that it could be an effective and safe option, maintaining normal functioning of VV-ECMO and reducing bleeding events. In practice, rhTM was found to effectively prevent thrombotic complications and minimize bleeding events during VV-ECMO.

ANNALS OF PALLIATIVE MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Low vs standardized dose anticoagulation regimens for extracorporeal membrane oxygenation: A meta-analysis

Xiaochai Lv et al.

Summary: This study showed that in ECMO patients, low-dose anticoagulation (LA) compared to standard-dose anticoagulation (SA) can reduce the incidence of gastrointestinal tract hemorrhage and surgical site hemorrhage. There were no significant differences in other complications between the two groups.

PLOS ONE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study

Bruce Cartwright et al.

Summary: This study found significant differences in coagulation profiles and thrombin generation between patients supported with VA and VV ECMO, with VA patients showing a more pronounced consumptive coagulopathy and higher thrombin generation. VA patients required a lower heparin dose to suppress thrombin generation. Despite these differences, there were no significant variations in bleeding or thrombotic event rates between VV and VA patients when adjusted for days on ECMO support. More research is needed to develop tailored anticoagulation strategies based on the mode of ECMO support.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Review Medicine, General & Internal

Heparin Resistance - Clinical Perspectives and Management Strategies

Jerrold H. Levy et al.

Summary: Heparin resistance occurs when higher doses of heparin are needed to achieve the therapeutic range of activated partial-thromboplastin time, and management may involve increasing the heparin dose, supplementing antithrombin III levels, and using direct thrombin inhibitors.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Satisfactory outcome with low activated clotting time in extracorporeal membrane oxygenation

Jeong In Hong et al.

Summary: This study investigated the impact of a lower target ACT during ECMO on safety and outcomes, finding that it did not increase the thromboembolic risk compared to a conventional ACT target. Clinicians may consider using a lower ACT target for anticoagulation in some patients with careful assessment and close monitoring. Further prospective trials are needed to validate these results.

REVIEWS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

S3 Guideline of Extracorporeal Circulation (ECLS/ECMO) for Cardiocirculatory Failure

Udo Boeken et al.

THORACIC AND CARDIOVASCULAR SURGEON (2021)

添加到收藏夹

Article Critical Care Medicine

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study

Christoph Fisser et al.

Summary: In patients without HIT on vvECMO, Argatroban was non-inferior to UFH regarding bleeding and thrombosis. The occurrence of technical complications was similarly distributed. Argatroban may have less impact on platelet decrease during ECMO, but this finding needs further evaluation. Direct drug costs were higher for Argatroban but comparable to UFH after accounting for HIT-testing and transfusions.

CRITICAL CARE (2021)

添加到收藏夹

Article Critical Care Medicine

Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study

Richard Descamps et al.

Summary: In patients under ECMO support, mean anti-Xa activity was identified as an independent risk factor for hemorrhagic complications. Anticoagulation targets may need to be revised downward in both VV- and VA-ECMO.

CRITICAL CARE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Cost-effectiveness of Argatroban Versus Heparin Anticoagulation in Adult Extracorporeal Membrane Oxygenation Patients

Angelina E. Cho et al.

Summary: This study aimed to evaluate the cost effectiveness of argatroban versus heparin during ECMO therapy, showing that argatroban had lower average cost per course and no increased risk of adverse events.

HOSPITAL PHARMACY (2021)

添加到收藏夹

Article Critical Care Medicine

Anticoagulation Monitoring Under ECMO Support: A Comparative Study Between the Activated Coagulation Time and the Anti-Xa Activity Assay

Clement Delmas et al.

JOURNAL OF INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Article Engineering, Biomedical

Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support

Serena Arnouk et al.

ASAIO JOURNAL (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation

Kristopher B. Deatrick et al.

PERFUSION-UK (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation

Matthew J. Morrisette et al.

PERFUSION-UK (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Venoarterial-Extracorporeal Membrane Oxygenation Without Routine Systemic Anticoagulation Decreases Adverse Events

Katherine L. Wood et al.

ANNALS OF THORACIC SURGERY (2020)

添加到收藏夹

Article Engineering, Biomedical

Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients

Johannes Gratz et al.

ARTIFICIAL ORGANS (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation

Haya Kaseer et al.

JOURNAL OF CARDIAC SURGERY (2020)

添加到收藏夹

Article Hematology

Argatroban dosing requirements in extracorporeal life support and other critically ill populations

J. Spencer Dingman et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Feasibility of Venovenous Extracorporeal Membrane Oxygenation Without Systemic Anticoagulation

Chitaru Kurihara et al.

ANNALS OF THORACIC SURGERY (2020)

添加到收藏夹

Review Critical Care Medicine

Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis

Federica Jiritano et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Article Respiratory System

Extracorporeal membrane oxygenation without systemic anticoagulation: a case-series in challenging conditions

Dario Fina et al.

JOURNAL OF THORACIC DISEASE (2020)

添加到收藏夹

Article Critical Care Medicine

A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation

Mauro Panigada et al.

CRITICAL CARE MEDICINE (2020)

添加到收藏夹

Article Critical Care Medicine

Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure

Benjamin Seeliger et al.

CRITICAL CARE (2020)

添加到收藏夹

Review Critical Care Medicine

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO

Meghan M. Chlebowski et al.

CRITICAL CARE (2020)

添加到收藏夹

Article Engineering, Biomedical

Antithrombin During Extracorporeal Membrane Oxygenation in Adults: National Survey and Retrospective Analysis

Giacomo E. Iapichino et al.

ASAIO JOURNAL (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

A comparison of low and standard anti-coagulation regimens in extracorporeal membrane oxygenation

Jaishankar Raman et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)

添加到收藏夹

Article Critical Care Medicine

Low-Dose Versus Therapeutic Anticoagulation in Patients on Extracorporeal Membrane Oxygenation: A Pilot Randomized Trial

Cecile Aubron et al.

CRITICAL CARE MEDICINE (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy

Shea Macielak et al.

PERFUSION-UK (2019)

添加到收藏夹

Article Hematology

Frequency and Clinical Impact of Platelet Factor 4-Specific Antibodies in Patients Undergoing Extracorporeal Membrane Oxygenation

Caroline Vayne et al.

THROMBOSIS AND HAEMOSTASIS (2019)

添加到收藏夹

Article Engineering, Biomedical

ECMO without anticoagulation in patients with disease-related severe thrombocytopenia: Feasible but futile?

Alexander Hermann et al.

ARTIFICIAL ORGANS (2019)

添加到收藏夹

Article Critical Care Medicine

Hemorrhagic complications during extracorporeal membrane oxygenation - The role of anticoagulation and platelets

Annemieke Oude Lansink-Hartgring et al.

JOURNAL OF CRITICAL CARE (2019)

添加到收藏夹

Article Surgery

Heparin-Sparing Anticoagulation Strategies Are Viable Options for Patients on Veno-Venous ECMO

Kristen T. Carter et al.

JOURNAL OF SURGICAL RESEARCH (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Post-cardiotomy venovenous extracorporeal membrane oxygenation without heparinization

Masami Takagaki et al.

GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes

Jae Hwan Choi et al.

ANNALS OF CARDIOTHORACIC SURGERY (2019)

添加到收藏夹

Article Emergency Medicine

D-dimer predicts bleeding complication in out-of-hospital cardiac arrest resuscitated with ECMO

Takayuki Otani et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2018)

添加到收藏夹

Review Anesthesiology

Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery

Andreas Koster et al.

ANESTHESIOLOGY (2018)

添加到收藏夹

Article Engineering, Biomedical

Soluble fibrin is a useful marker for predicting extracorporeal membrane oxygenation circuit exchange because of circuit clots

Kota Hoshino et al.

JOURNAL OF ARTIFICIAL ORGANS (2018)

添加到收藏夹

Article Critical Care Medicine

Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study

Mauro Panigada et al.

ANNALS OF INTENSIVE CARE (2018)

添加到收藏夹

Article Engineering, Biomedical

Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation

Theodore J. Berei et al.

ASAIO JOURNAL (2018)

添加到收藏夹

Article Critical Care Medicine

Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study

Antoine Kimmoun et al.

INTENSIVE CARE MEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia Analysis of 10 consecutive patients

Young Su Kim et al.

MEDICINE (2018)

添加到收藏夹

Article Hematology

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

Adam Cuker et al.

BLOOD ADVANCES (2018)

添加到收藏夹

Article Engineering, Biomedical

Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients

Kirsten Krueger et al.

ARTIFICIAL ORGANS (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Externally visible thrombus partially predicts internal thrombus deposition in extracorporeal membrane oxygenators

Charles F. Evans et al.

PERFUSION-UK (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients

Kalliopi Fitousis et al.

PERFUSION-UK (2017)

添加到收藏夹

Article Anesthesiology

The HAT Score A Simple Risk Stratification Score for Coagulopathic Bleeding During Adult Extracorporeal Membrane Oxygenation

Terence Lonergan et al.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2017)

添加到收藏夹

Review Hematology

Autoimmune heparin-induced thrombocytopenia

A. Greinacher et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)

添加到收藏夹

Article Critical Care Medicine

Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support

Mario Menk et al.

ANNALS OF INTENSIVE CARE (2017)

添加到收藏夹

Article Engineering, Biomedical

Extracorporeal Life Support Organization Registry International Report 2016

Ravi R. Thiagarajan et al.

ASAIO JOURNAL (2017)

添加到收藏夹

Article Engineering, Biomedical

Is Stopping Heparin Safe in Patients on Extracorporeal Membrane Oxygenation Treatment?

Yoon Sang Chung et al.

ASAIO JOURNAL (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR)

Kilsoo Yie et al.

PERFUSION-UK (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Anticoagulation During Extracorporeal Membrane Oxygenation; Nafamostat Mesilate Versus Heparin

Ju Yong Lim et al.

ANNALS OF THORACIC SURGERY (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Agreement between ACT and aPTT during extracorporeal membrane oxygenation shows intra- and inter-individual variation

David Cunningham et al.

PERFUSION-UK (2016)

添加到收藏夹

Review Hematology

Antithrombin: anti-inflammatory properties and clinical applications

Jerrold H. Levy et al.

THROMBOSIS AND HAEMOSTASIS (2016)

添加到收藏夹

Article Critical Care Medicine

Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis

Franziska C. Trudzinski et al.

ANNALS OF INTENSIVE CARE (2016)

添加到收藏夹

Article Anesthesiology

Discordance between ROTEM® clotting time and conventional tests during unfractionated heparin based anticoagulation in intensive care patients on extracorporeal membrane oxygenation

S. Prakash et al.

ANAESTHESIA AND INTENSIVE CARE (2016)

添加到收藏夹

Letter Critical Care Medicine

Low-dose heparin during extracorporeal membrane oxygenation treatment in adults

Hye Ju Yeo et al.

INTENSIVE CARE MEDICINE (2015)

添加到收藏夹

Article Engineering, Biomedical

Nafamostat mesilate as a regional anticoagulant in patients with bleeding complications during extracorporeal membrane oxygenation

Jin-Han Park et al.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2015)

添加到收藏夹

Article Anesthesiology

Prospective Observational Study of Hemostatic Alterations During Adult Extracorporeal Membrane Oxygenation (ECMO) Using Point-of-Care Thromboelastometry and Platelet Aggregometry

Priya Nair et al.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2015)

添加到收藏夹

Article Critical Care Medicine

The Use of an Extracorporeal Membrane Oxygenation Anticoagulation Laboratory Protocol Is Associated With Decreased Blood Product Use, Decreased Hemorrhagic Complications, and Increased Circuit Life

Michael S. Northrop et al.

PEDIATRIC CRITICAL CARE MEDICINE (2015)

添加到收藏夹

Article Critical Care Medicine

Use of a fixed, body weight-unadjusted loading dose of unfractionated heparin for extracorporeal cardiopulmonary resuscitation

Yoshiaki Iwashita et al.

JOURNAL OF INTENSIVE CARE (2015)

添加到收藏夹

Article Medical Laboratory Technology

The Influence of Free Hemoglobin and Bilirubin on Heparin Monitoring by Activated Partial Thromboplastin Time and Anti-Xa Assay

Vadim Kostousov et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)

添加到收藏夹

Article Engineering, Biomedical

Antithrombin III Supplementation on Extracorporeal Membrane Oxygenation Impact on Heparin Dose and Circuit Life

Jonathan W. Byrnes et al.

ASAIO JOURNAL (2014)

添加到收藏夹

Article Critical Care Medicine

D-dimers as an early marker for oxygenator exchange in extracorporeal membrane oxygenation

Matthias Lubnow et al.

JOURNAL OF CRITICAL CARE (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients

S. Atallah et al.

PERFUSION-UK (2014)

添加到收藏夹

Article Pathology

Fresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation

Elizabeth A. Gilman et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)

添加到收藏夹

Article Anesthesiology

Bivalirudin Versus Heparin as an Anticoagulant During Extracorporeal Membrane Oxygenation: A Case-Control Study

Marina Pieri et al.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2013)

添加到收藏夹

Article Engineering, Biomedical

Addition of Acetylsalicylic Acid to Heparin for Anticoagulation Management During Pumpless Extracorporeal Lung Assist

Thomas Bein et al.

ASAIO JOURNAL (2011)

添加到收藏夹

Article Medicine, General & Internal

Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation

Sang Jin Han et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2011)

添加到收藏夹

Article Critical Care Medicine

Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation

Marco Ranucci et al.

CRITICAL CARE (2011)

添加到收藏夹

Article Hematology

Monitoring direct thrombin inhibitors with a plasma diluted thrombin time

Jason E. Love et al.

THROMBOSIS AND HAEMOSTASIS (2007)

添加到收藏夹

Article Engineering, Biomedical

Argatroban in extracorporeal membrane oxygenation

Martin Beiderlinden et al.

ARTIFICIAL ORGANS (2007)

添加到收藏夹

Article Pathology

Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin

Christopher M. Lehman et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)

添加到收藏夹

Article Hematology

Risk for heparin-induced thrombocytopenia. with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis

N Martel et al.

BLOOD (2005)

添加到收藏夹

Article Pharmacology & Pharmacy

Quantification of heparin-induced TFPI release: a maximum release at low heparin dose

MJB Kemme et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.